Skip to main content
BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
106.33
-0.24 (-0.23%)
At close: Jun 16, 2025, 4:00 PM
106.13
-0.20 (-0.19%)
Pre-market: Jun 17, 2025, 4:00 AM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 TTM FY 2024 FY 2023 FY 2022 FY 2021 2017 - 2020
Period Ending
 Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 2017 - 2020
COVID-19 Vaccine Revenue (Post-FY2023 Reporting)
2.44B
Log In
Log In
Log In
Log In
Upgrade
COVID-19 Vaccine Revenue (Post-FY2023 Reporting) Growth
-7.43%
Log In
Log In
Log In
Log In
Upgrade
Other Sales Revenue (Post-FY2023 Reporting)
305.40M
Log In
Log In
Log In
Log In
Upgrade
Other Sales Revenue (Post-FY2023 Reporting) Growth
229.45%
Log In
Log In
Log In
Log In
Upgrade
Research & Development
-
Log In
Log In
Log In
Log In
Upgrade
Research & Development Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other Sales Revenue (Pre-FY2024 Reporting)
-
Log In
Log In
Log In
Log In
Upgrade
Other Sales Revenue (Pre-FY2024 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade
COVID-19 Vaccine Revenue (Pre-FY2024 Reporting)
-
Log In
Log In
Log In
Log In
Upgrade
COVID-19 Vaccine Revenue (Pre-FY2024 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade